200 related articles for article (PubMed ID: 24917455)
41. Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women.
Richert-Spuhler LE; Pattacini L; Plews M; Irungu E; Muwonge TR; Katabira E; Mugo N; Meyers AFA; Celum C; Baeten JM; Lingappa JR; Lund JM
AIDS; 2019 Nov; 33(14):2125-2136. PubMed ID: 31335802
[TBL] [Abstract][Full Text] [Related]
42. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
[TBL] [Abstract][Full Text] [Related]
43. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
Schiffer JT; Abu-Raddad L; Mark KE; Zhu J; Selke S; Koelle DM; Wald A; Corey L
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18973-8. PubMed ID: 20956313
[TBL] [Abstract][Full Text] [Related]
44. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge.
Zhang X; Chentoufi AA; Dasgupta G; Nesburn AB; Wu M; Zhu X; Carpenter D; Wechsler SL; You S; BenMohamed L
Mucosal Immunol; 2009 Mar; 2(2):129-143. PubMed ID: 19129756
[TBL] [Abstract][Full Text] [Related]
45. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
van Velzen M; Jing L; Osterhaus AD; Sette A; Koelle DM; Verjans GM
PLoS Pathog; 2013 Aug; 9(8):e1003547. PubMed ID: 23966859
[TBL] [Abstract][Full Text] [Related]
46. Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract.
Schiffer JT; Swan D; Al Sallaq R; Magaret A; Johnston C; Mark KE; Selke S; Ocbamichael N; Kuntz S; Zhu J; Robinson B; Huang ML; Jerome KR; Wald A; Corey L
Elife; 2013 Apr; 2():e00288. PubMed ID: 23606943
[TBL] [Abstract][Full Text] [Related]
47. Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection.
Mesquita PMM; Preston-Hurlburt P; Keller MJ; Vudattu N; Espinoza L; Altrich M; Anastos K; Herold KC; Herold BC
J Infect Dis; 2017 Feb; 215(4):614-622. PubMed ID: 28007920
[TBL] [Abstract][Full Text] [Related]
48. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.
Koelle DM; Abbo H; Peck A; Ziegweid K; Corey L
J Infect Dis; 1994 May; 169(5):956-61. PubMed ID: 8169426
[TBL] [Abstract][Full Text] [Related]
49. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses.
Posavad CM; Koelle DM; Shaughnessy MF; Corey L
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10289-94. PubMed ID: 9294203
[TBL] [Abstract][Full Text] [Related]
50. Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.
Shust GF; Cho S; Kim M; Madan RP; Guzman EM; Pollack M; Epstein J; Cohen HW; Keller MJ; Herold BC
Am J Reprod Immunol; 2010 Feb; 63(2):110-9. PubMed ID: 20015330
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
Milligan GN; Dudley-McClain KL; Chu CF; Young CG
Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
[TBL] [Abstract][Full Text] [Related]
52. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.
Hosken N; McGowan P; Meier A; Koelle DM; Sleath P; Wagener F; Elliott M; Grabstein K; Posavad C; Corey L
J Virol; 2006 Jun; 80(11):5509-15. PubMed ID: 16699031
[TBL] [Abstract][Full Text] [Related]
53. A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.
Odegard JM; Flynn PA; Campbell DJ; Robbins SH; Dong L; Wang K; Ter Meulen J; Cohen JI; Koelle DM
Vaccine; 2016 Jan; 34(1):101-9. PubMed ID: 26571309
[TBL] [Abstract][Full Text] [Related]
54. Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions.
Nelson MH; Bird MD; Chu CF; Johnson AJ; Friedrich BM; Allman WR; Milligan GN
J Reprod Immunol; 2011 Apr; 89(1):10-7. PubMed ID: 21444117
[TBL] [Abstract][Full Text] [Related]
55. Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells.
Danke NA; Koelle DM; Kwok WW
Hum Immunol; 2005 Jul; 66(7):777-87. PubMed ID: 16112025
[TBL] [Abstract][Full Text] [Related]
56. Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4
Bourne N; Perry CL; Banasik BN; Miller AL; White M; Pyles RB; Schäfer H; Milligan GN
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463981
[TBL] [Abstract][Full Text] [Related]
57. Immunoregulatory Functions of Interferons During Genital HSV-2 Infection.
Feng E; Balint E; Vahedi F; Ashkar AA
Front Immunol; 2021; 12():724618. PubMed ID: 34484233
[TBL] [Abstract][Full Text] [Related]
58. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.
Ashley R; Wald A; Corey L
J Virol; 1994 Aug; 68(8):5284-6. PubMed ID: 8035526
[TBL] [Abstract][Full Text] [Related]
59. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
[TBL] [Abstract][Full Text] [Related]
60. Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells.
Morrison LA
Virology; 2008 Jun; 376(1):205-10. PubMed ID: 18410949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
